HPLC-UV comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-07-18. Numbers and descriptions here follow the published literature rather than marketing material.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule nuclear receptor ligand |
| Appearance | Off-white to pale yellow solid | Typical for research-grade powder |
| Solubility class | Soluble in DMSO; low water solubility | Common stock solutions use organic solvent |
| Typical stock solvent | Dimethyl sulfoxide | Used for laboratory assays |
| Common analytical method | HPLC with UV or mass detection | Used for identity and purity checks |
Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
=== Pulmonary embolism === Pulmonary embolism (blood clots that have moved to the lung arteries) is usually treated with heparin generally followed by warfarin. If pulmonary embolism causes severe instability due to high pressure on the heart ("massive PE") and leads to low blood pressure, recombinant tPA is recommended.
=== Methodology === A sample of water is collected in the field in a vial without headspace and capped with a Teflon septum or crimp top to minimize the escape of volatile gases. It is beneficial to store the bottles upside down to further minimize loss of analytes. Before analysis begins, the sample is brought to room temperature and temperature is recorded. In the laboratory, a headspace is created by displacing water with high purity helium. The bottle is then shaken upside down for a minimum of five minutes in order to equilibrate the dissolved gases into the headspace. It's important to note that the bottle must be kept upside down for the remainder of analysis if manually injected. A known volume of headspace gas is then injected onto a gas chromatographic column. An automated process can also be utilized. Individual components (gases) are separated and detected by either a thermal conductivity detector (TCD), a flame ionization detector (FID), or an electron capture detector (ECD). Using the known temperature of the sample, the bottle volume, the concentrations of gas in the headspace (as determined by GC), and Henry's law constant, the concentration of the original water sample is calculated.
Varying concentrations of Asparagopsis taxiformis were mixed with Rhodes grass and examined using standardised in vitro culture methods. Five dosages were tested ranging from 0.5% to 10% of dietary composition. The optimum concentration was determined to be 2%, as it virtually eliminated methane production and reduced the volume of total gases produced by 30% without affecting fermentation efficiency. Dosages under 5% had no effect on volatile fatty acid concentrations, which is the primary source of energy resulting from digestion. In 2016, live tests were performed on sheep at the CSIRO Centre for Environment and Life Sciences in Floreat, Western Australia. 29 merino sheep were fed one of five dosage levels (0%, 0.5%, 1%, 2% or 3% dietary intake) and monitored over a 72-day feeding period. In dosages of 2%, methane emission reductions of up to 85% were recorded when compared to control sheep. The sheep given dosages of 0.5% recorded at least a 50% reduction in methane emissions. No evidence of microbial adaptation occurred over the 72 days of testing and methane was continually and consistently mitigated. Tissue examination showed no adverse effects on the overall health of the sheep. In 2017, live tests over 90 days were performed on cattle at the CSIRO Lansdown facility in Queensland. 28 Brahman-Angus steers were separated into four groups and given varying dosages of dried Asparagopsis in a simulated feedlot. Concentration levels for each group were 0% (control), 0.5% (low), 1% (medium) and 2% (high) intake of Asparagopsis.
phytate), disease and metabolic disorders (e.g. environmental enteric dysfunction), the reproductive cycle, quantity of mineral in diet, chronic mineral deficiency, subject age and homeostatic mechanisms. When results from such studies are available for a mineral, they may serve as a basis for estimations of the human physiological and dietary requirements of the mineral. When tracer is administered with food for the purpose of observing mineral absorption and metabolism, it may be in the form of an intrinsic or extrinsic label. An intrinsic label is isotope that has been introduced into the food during its production, thus enriching the natural mineral content of the food, whereas extrinsic labeling refers to the addition of tracer isotope to the food during the study. Because it is a very time-consuming and expensive approach, intrinsic labeling is not routinely used. Studies comparing measurements of absorption using intrinsic and extrinsic labeling of various foods have generally demonstrated good agreement between the two labeling methods, supporting the hypothesis that extrinsic and natural minerals are handled similarly in the human gastrointestinal tract. Enrichment is quantified from the measurement of isotope ratios, the ratio of the tracer isotope to a reference isotope, by mass spectrometry. Multiple definitions and calculations of enrichment have been adopted by different researchers. Calculations of enrichment become more complex when multiple tracers are used simultaneously. Because enriched isotope preparations are never isotopically pure, i.e.
Sources: en.wikipedia.org
=== Intrinsic properties and resistance === Polyvinylidene fluoride expresses inherent resistance characteristics in certain high-focus applications. Namely these are: ozone oxidation reactions, nuclear radiation, UV damage, and microbiological, fungus growth. PVDF's resistance to these conditions is fairly distinctive among thermoplastic materials. PVDF's carbon and fluoride elemental stability contributes to this resistance, as well as the polymeric integration of PVDF during its processing.
== A == abietadiene hydroxylase - acido-1 RNA motif -acrylamide gels - act 1 adaptor protein - actino-ugpB RNA motif - actinomyces-1 RNA motif - adenine - adenosine deaminase deficiency - adenovirus - adenylyl-(glutamate—ammonia ligase) hydrolase - agarose gel electrophoresis - agarose gel - akaryocyte - Alagille syndrome - alkaline lysis - allele - amino acids - amino terminus - amp resistance - amplification - amplicon - anchor sequence - animal model - anneal - anti-sense strand - antibiotic resistance - antibody - antisense - antisense strand - AP-1 site - apo-beta-carotenoid-14',13'-dioxygenase - apoptosis - apovitellenin-1 - archease - arenicin - ArgJ protein family - ascorbate 2,3-dioxygenase - assembled epitope - ataxia-telangiectasia - ATG or AUG - ATP cone - Atrial septal defect 1 - autoimmune lymphoproliferative syndrome - autoradiography - autosomal dominant - autosome - avidin -
==== Operation bootstrap (1948) ==== Operation Bootstrap was enacted in 1948 and was the result of Puerto Rico's desire to attract outside capital by inviting U.S. private funds. Therefore, a tax arrangement was made by the U.S. to improve the industrial production on the island in an effort to increase profits and funnel money to the mainland. This economic development program enticed industries within the U.S. that were in search of "cheap labor, tax exemptions, and free trade between Puerto Rico and the mainland". This rapid foreign investment provided promise for disadvantaged Puerto Rican women who were struggling to navigate through domestic working conditions and limited job opportunities. Operation Bootstrap was marketed and believed to be an advantageous new service sector for women in search of white collar jobs. However, Puerto Rican women and the vast majority of the island experienced the exact opposite. Operation Bootstrap resulted in "high unemployment, increased migration, exacerbated poverty", and most importantly, economic colonization.
== Medical uses == Probenecid is primarily used to treat gout and hyperuricemia. Probenecid is sometimes used to increase the concentration of some antibiotics and to protect the kidneys when given with cidofovir. Specifically, a small amount of evidence supports the use of intravenous cefazolin once rather than three times a day when it is combined with probenecid. It has also found use as a masking agent, potentially helping athletes using performance-enhancing substances to avoid detection by drug tests.
Mothers who take certain recreational drugs should not breastfeed, however, most medications are compatible with breastfeeding. Available evidence indicates that it is unlikely that COVID-19 can be transmitted through breast milk. Smoking tobacco and consuming limited amounts of alcohol or coffee are not reasons to avoid breastfeeding.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.
It binds REV-ERB alpha and REV-ERB beta and changes the expression of genes tied to metabolism and circadian rhythm. These changes can affect mitochondria and energy use in animal models. The exact chain from receptor binding to physiological outcome is still being mapped.
No reliable human trials show that SR9009 improves athletic performance. Some rodent studies report endurance changes, but these results are not proof of human benefit. Its use in sport is prohibited, and quality and safety data are lacking.
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.